Bacteriostatic agent

<h2 id="bacteriostatic-antibiotics">Bacteriostatic antibiotics</h2>
<p>Bacteriostatic antibiotics limit the growth of <a href="/facts/Bacteria/wC8xSCsU">bacteria</a> by interfering with bacterial <a href="/facts/Protein/Jxmagu3E">protein</a> production, <a href="/facts/DNA/nB89Iauz">DNA</a> replication, or other aspects of bacterial cellular <a href="/facts/Metabolism/WxDrm8k5">metabolism</a>. They must work together with the immune system to remove the microorganisms from the body.  However, there is not always a precise distinction between them and bactericidal antibiotics; high concentrations of some bacteriostatic agents are also bactericidal, whereas low concentrations of some <a href="/facts/Bactericidal/X1XwY97r">bactericidal</a> agents are bacteriostatic. This group<a class="footnote-ref" id="fnref:2" href="#fn:2"><sup>2</sup></a> includes:
</p>

<ul><li><a href="/facts/Chloramphenicol/4KQxQKvs">Chloramphenicol</a></li>
<li><a href="/facts/Clindamycin/n01yIK1x">Clindamycin</a></li>
<li><a href="/facts/Ethambutol/BT67zIyK">Ethambutol</a></li>
<li><a href="/facts/Lincosamides/UA20Ggmy">Lincosamides</a></li>
<li><a href="/facts/Macrolides/21qIKr7a">Macrolides</a></li>
<li><a href="/facts/Nitrofurantoin/AQv42cqM">Nitrofurantoin</a></li>
<li><a href="/facts/Novobiocin/PXYRaXsu">Novobiocin</a></li>
<li><a href="/facts/Oxazolidinone/T4By4daz">Oxazolidinone</a></li>
<li><a href="/facts/Spectinomycin/3yltFN9B">Spectinomycin</a></li>
<li><a href="/facts/Sulfonamide_(medicine)/4vXtwwwm">Sulfonamides</a></li>
<li><a href="/facts/Tetracyclines/IQx9gYrE">Tetracyclines</a></li>
<li><a href="/facts/Tigecycline/03JBAmzM">Tigecycline</a></li>
<li><a href="/facts/Trimethoprim/9sfURYaJ">Trimethoprim</a></li></ul>
<h2 id="see-also">See also</h2>
<ul><li><a href="/facts/List_of_antibiotics/b4QxXahn">List of antibiotics</a></li>
<li><a href="/facts/Oligodynamic_effect/uKE1lupq">Oligodynamic effect</a></li></ul>

<h2 id="references">References</h2>

<ol>
<li id="fn:1"><p>Pankey GA, Sabath LD (March 2004). "Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections". Clin. Infect. Dis. 38 (6): 864–70. doi:10.1086/381972. PMID 14999632. <a href="https://doi.org/10.1086%2F381972" target="_blank">https://doi.org/10.1086%2F381972</a> <a href="#fnref:1" class="footnote-back-ref">↩</a></p></li>
<li id="fn:2"><p>Shetty N, Aarons E, Andrews J (2009). "Chapter 5: General principles of antimicrobial therapy". In Andrews J, Shetty N, Tang JW (eds.). Infectious Disease: Pathogenesis, Prevention and Case Studies. Wiley-Blackwell. ISBN 978-1-4051-3543-6. <a href="978-1-4051-3543-6" target="_blank">978-1-4051-3543-6</a> <a href="#fnref:2" class="footnote-back-ref">↩</a></p></li>
</ol>

Bacteriostatic agent open-in-new

Bacteriostatic agent